دورية أكاديمية

Controlling Pharmaceutical Costs in a Student-Run Free Clinic in a Resource-Limited Patient Setting.

التفاصيل البيبلوغرافية
العنوان: Controlling Pharmaceutical Costs in a Student-Run Free Clinic in a Resource-Limited Patient Setting.
المؤلفون: He C; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Kalagara R; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Chennareddy S; Icahn School of Medicine at Mount Sinai, New York, NY, USA. sumanth.chennareddy@icahn.mssm.edu., Rodriguez N; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Vahanan M; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Mohammad A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Skovran D; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Meah Y; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
المصدر: Journal of community health [J Community Health] 2023 Dec; Vol. 48 (6), pp. 913-918. Date of Electronic Publication: 2023 Jul 05.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 7600747 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3610 (Electronic) Linking ISSN: 00945145 NLM ISO Abbreviation: J Community Health Subsets: MEDLINE
أسماء مطبوعة: Publication: Amsterdam : Springer
Original Publication: New York, Human Sciences Press.
مواضيع طبية MeSH: Student Run Clinic* , Prescription Drugs*/therapeutic use, Humans ; Ambulatory Care Facilities ; Drug Costs ; Medically Uninsured
مستخلص: Our institution's student-run free clinic has been able to offer medication at no out-of-pocket cost to all patients since it opened in 2004. We have employed two strategies to manage prescription drug costs while simultaneously increasing medication coverage: (1) using Patient Drug Assistance Programs (PDAPs) and (2) developing an institutional-level partnership with pharmaceutical charities for medication subsidization. In this study, we aimed to analyze the financial impact of these measures on the clinic.A query of clinic data over the past 5 years identified 299 active PDAPs, corresponding to 299 fully-subsidized prescriptions. In 2017, there were 35 active PDAPs, increasing to 52 (2018), 62 (2019), and 82 (2020) before a decline to 68 PDAPs in 2021. The company affiliated with the most PDAPs varied annually: GlaxoSmithKline (2017), Lilly (2018, 2019, 2020), and both GlaxoSmithKline and Lilly (2021). The most frequent medications were sitagliptin (2017), insulin (2018, 2019), albuterol (2017, 2018), and dulaglutide (2020, 2021).In addition, data extracted from the private company subsidization program was analyzed for the year 2021. Program membership was $10,000 for institution-wide medication subsidization for all uninsured patients in the hospital system. In total, the clinic was able to acquire 220 medications with a 96% subsidy, corresponding to a direct clinic cost of $2,101.28. Comparatively, the market value of these medications was $52,401.51.Utilization of free drug acquisition programs and partnerships with pharmaceutical charities allowed for an increase in cost-savings and medications provided. Although the process for applying for medication assistance programs is complex, these programs serve as powerful tools for providing medications that may otherwise be unavailable due to cost. Other clinics and healthcare settings with uninsured patients should consider these programs as a means to ease medication cost burden.
(© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
References: Donohue, J. M.et al., (2011). “Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression,“ Am J Geriatr Psychiatry, vol. 19, no. 12, pp. 989 – 97, Dec https://doi.org/10.1097/JGP.0b013e3182051a9b.
Piette, J. D., Wagner, T. H., Potter, M. B., & Schillinger, D. (Feb 2004). Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care. Medical Care, 42(2), 102–109. https://doi.org/10.1097/01.mlr.0000108742.26446.17.
Fernandez-Lazaro, C. I., Adams, D. P., Fernandez-Lazaro, D., Garcia-Gonzalez, J. M., Caballero-Garcia, A., & Miron-Canelo, J. A. (Jun 2019). Medication adherence and barriers among low-income, uninsured patients with multiple chronic conditions. Res Social Adm Pharm, 15(6), 744–753. https://doi.org/10.1016/j.sapharm.2018.09.006.
Choudhry, N. K. “Full coverage for preventive medications after myocardial infarction,“ N Engl J Med, vol. 365, no. 22, pp. 2088-97, Dec 1 2011, https://doi.org/10.1056/NEJMsa1107913.
Afendulis, C. C., He, Y., Zaslavsky, A. M., & Chernew, M. E. (Aug 2011). The impact of Medicare Part D on hospitalization rates. Health Services Research, 46(4), 1022–1038. https://doi.org/10.1111/j.1475-6773.2011.01244.x.
Hinterland, K., et al. (2018). Community health profiles 2018. Brooklyn Community District, 17, 1–20.
Jaya, B. “Containing Prescription Drug Costs at a Resource-Limited, Student-Run Clinic for the Uninsured,“ Journal of Student-Run Clinics, vol. 3, no. 1, 08/27 2017. [Online]. Available: https://journalsrc.org/index.php/jsrc/article/view/59.
فهرسة مساهمة: Keywords: Free Clinic; Patient Drug Assistance Program; Safety Net; Uninsured
المشرفين على المادة: 0 (Prescription Drugs)
تواريخ الأحداث: Date Created: 20230705 Date Completed: 20231009 Latest Revision: 20231202
رمز التحديث: 20231202
DOI: 10.1007/s10900-023-01232-6
PMID: 37405614
قاعدة البيانات: MEDLINE
الوصف
تدمد:1573-3610
DOI:10.1007/s10900-023-01232-6